CD274 and urinary bladder carcinoma: To further examine the potential usefulness of the Raf activation pathway as an ICI-treatment biomarker, we analyzed the association among PD-L1 expression, the TMB and the expression level of Raf activation components with the overall survival in an external TCGA bladder cancer dataset (n = 405).